Elevated Faecal Calprotectin Predicts Disease Progression in Crohn's Disease

被引：0
|
作者：
Kennedy, Nicholas A.
Chang, Jeff
Guy, Miriam
Smith, Tom
Loh, Joash T.
Haunschmidt, David
Muscat, Martina
Spurio, Federica Fasci
Drummond, Hazel E.
Kingstone, Kathleen
Noble, Colin
Shand, Alan G.
Satsangi, Jack
Arnott, Ian D.
Lees, Charlie W.
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] Diagnosis and differentiation of intestinal tuberculosis and Crohn's disease by use of faecal and serum calprotectin.
    Larsson, G.
    Shenoy, K.
    Roseth, A.
    Bjune, G.
    Moum, B.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S35 - S35
  • [42] The association of faecal calprotectin level and combined mucosal and transmural healing in patients with Crohn's disease
    Noh, S.
    Oh, E. H.
    Park, S. H.
    Lee, J. B.
    Kim, J. Y.
    Park, J. C.
    Kim, J.
    Ham, N.
    Song, E. M.
    Hwang, S. W.
    Yang, D. H.
    Byeon, J. S.
    Myung, S. J.
    Yang, S. K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S68 - S70
  • [43] Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence
    Baillet, Pierre
    Cadiot, Guillaume
    Goutte, Marion
    Goutorbe, Felix
    Brixi, Hedia
    Hoeffel, Christine
    Allimant, Christophe
    Reymond, Maud
    Obritin-Guilhen, Helene
    Magnin, Benoit
    Bommelaer, Gilles
    Pereira, Bruno
    Hordonneau, Constance
    Buisson, Anthony
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (05) : 641 - 650
  • [44] HISTOLOGICAL ACTIVITY IN CROHN'S DISEASE: RELATIONSHIP WITH CLINICAL INDICES, ENDOSCOPIC ACTIVITY AND FAECAL CALPROTECTIN
    Buisson, Anthony
    Mak, Wing Yan
    Andersen, Michael J.
    Lei, Donald
    Pekow, Joel R.
    Cohen, Russell D.
    Pereira, Bruno
    Setia, Namrata
    Weber, Christopher R.
    Hart, John A.
    Rubin, David T.
    GASTROENTEROLOGY, 2018, 154 (06) : S592 - S593
  • [45] Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease?
    Yamamoto, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (03) : 321 - 321
  • [46] Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study
    Stawczyk-Eder, Kamila
    Eder, Piotr
    Lykowska-Szuber, Liliana
    Krela-Kazmierczak, Iwona
    Klimczak, Katarzyna
    Szymczak, Aleksandra
    Szachta, Patrycja
    Katulska, Katarzyna
    Linke, Krzysztof
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 353 - 361
  • [47] Does faecal Calprotectin help differentiate inflammatory from fibrous stenosis in Crohn's disease?
    Ben Farhat, E.
    Sabbah, M.
    Ben Abid, M.
    Bibani, N.
    Bellil, N.
    Aoun, K.
    Bouratbine, A.
    Cargouri, D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S277 - S278
  • [48] Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy
    Turvill, James
    FRONTLINE GASTROENTEROLOGY, 2014, 5 (03) : 167 - 175
  • [49] MRI IS CORRELATED TO FAECAL CALPROTECTIN LEVEL IN THE EVALUATION OF SMALL BOWEL AND COLONIC CROHN'S DISEASE
    Makanyanga, J.
    Pendse, D.
    Atkins, E.
    Menys, A.
    Bloom, S.
    McCartney, S.
    Punwani, S.
    Halligan, S.
    Taylor, S.
    GUT, 2012, 61 : A392 - A392
  • [50] PREBOTICS AS PRIMARY PREVENTION OF CROHN'S DISEASE: IMPACT ON LUMINAL MICROBIOLOGY AND ELEVATED FAECAL CALPROTECTIN IS GREATER IN HEALTHY SIBLINGS THAN IN PATIENTS
    Hedin, C. R.
    Louis, P.
    Farquharson, F.
    McCartney, S.
    Stagg, A. J.
    Lindsay, J. O.
    Whelan, K.
    GUT, 2012, 61 : A171 - A171
12345